FDA Inspection 1161637 — Venkatesh Nadar, M.D.
The FDA completed an inspection of Venkatesh Nadar, M.D. on Jan 31, 2022 in Camp Hill, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 31, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Camp Hill, PA (United States)
Additional Details
Clinical Investigator (CI)